MedTrace Logo

Management of Anticoagulants and Antithrombotics in Patients With CSDH

NCT05079295 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2022-11-03

No results posted yet for this study

Summary

Primary objective of the study will be to compare, up to 6 months after surgery, number of relapses (post operative re-bleeding) or intracerebral hemorrhage (others than subdural hematomas) and thromboembolic or cardiovascular ischemic events, in patients undergoing surgery for chronic subdural hematoma (CSDH). These data will be correlated to the suspension or not of antithrombotics or anticoagulants before surgery or their re-introduction after surgery.

Conditions

  • Chronic Subdural Hematoma
  • Anticoagulant-induced Bleeding
  • Thromboembolic Stroke
  • Cardiovascular Stroke

Interventions

PROCEDURE

CSDH evacuation

Burr hole for chronic subdural hematomas

Sponsors & Collaborators

  • University Hospital of Ferrara

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-20
Primary Completion
2023-02-20
Completion
2024-02-20
FDA Drug
Yes

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05079295 on ClinicalTrials.gov